Negev Capital
Founded 2021
About Negev Capital
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$21+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, and therapeutic use of psychedelic interventions for neuropsychiatric disorders; as well as those who have excellent management and science teams, and robust IP. Negev believes that psychedelic medications will be not only disruptive to the practice of psychiatry but hold the potential to reduce enormous amounts of human suffering, and is committed to helping the field mature, and further promote ways for these treatments to reach all of those in need.
Company Facts
- Founded: 2021
- Operating status: Operating
- IPO status: Private
- Employees: 1 – 10
- Website: negevcap.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/negev-capital-8397384 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.